Live news related to GUERBET stock (FR0000032526): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on GUERBET mainly cover earnings publications et M&A activity. The stock trades at €10,76 on Euronext Paris, up 0,56% at the last update. This page lists the articles published on GUERBET stock to track the share price, company announcements and any item likely to influence market perception.
On Friday, Guerbet announced a reshuffling of its board of directors following its general assembly on May 22, 2026. Antoine Fady has been appointed a…
The stock of the medical imaging contrast agent specialist soared this Monday, April 27, 2026, showing an increase of over 7% in mid-afternoon. This s…
Guerbet reported a first-quarter revenue of 177.4 million euros for 2026, up 2.6% on a constant exchange rate and comparable scope basis. This growth,…
On Tuesday midday, Guerbet's stock price increased by 5.72%, trading at 10.54 euros after closing at 9.97 euros the previous day. This surge comes wit…
Guerbet announces the appointment of Antoine Fady as censor effective immediately, decided during the Board of Directors meeting on March 11, 2026. He…
In 2025, Guerbet recorded a turnover of €786.4 million, a decrease of 3.5% at constant exchange rates and comparable scope. Despite this contraction, …
Medical imaging specialist Guerbet recorded an annual revenue of 786.4 million euros in 2025, down by 6.5% year-on-year. At constant exchange rates an…
Guerbet announces the appointment of Karim Boussebaa as the CEO of the group, effective February 2, 2026.
Guerbet Group announces the appointment of François Convenant as Senior Vice-President of Interventional Radiology and his entry into the executive co…
